DGI Clinical is a boutique Contract Research Organization (CRO) developing tools for patient-centered research and care. We produce shared decision-making tools which shift the entire dialogue between clinicians, patients, their families and the greater care team. We also use tools at the cutting edge of data science, enabling an individualized approach to medical research that is inherently clinically meaningful. Grounded in decades of research, our approach uses a modified Goal Attainment Scaling (GAS) methodology to produce patient-centered outcome measures in the form of eCOAs; these are valid, reliable, and responsive measures tailor-made for the clinical trial setting. Our roots are in dementia and CNS and we have many patient-centered outcome measures ready for use in these areas. We also work in partnership with sponsors to develop bespoke eCOAs, including a recent tool developed for hemophilia. Our partners and clients include Shire, Elan, Baxalta, Otsuka, Roche, Nutricia, Janssen, Pfizer, Novartis, GlaxoSmithKline and more.
Looking for a particular DGI Clinical employee's phone or email?
The DGI Clinical annual revenue was $11 million in 2026.
Paul Dowie is the Board Chair of DGI Clinical.
3 people are employed at DGI Clinical.
DGI Clinical is based in Halifax, Nova Scotia.
The NAICS codes for DGI Clinical are [6215, 62151, 621, 62].
The SIC codes for DGI Clinical are [80, 807].